| Literature DB >> 23807547 |
Nathalie Legrave1, Souhir Hamrouni-Buonomo, Maeva Dufies, Vincent Guérineau, Jean Vacelet, Patrick Auberger, Philippe Amade, Mohamed Mehiri.
Abstract
A new C47 polyoxygenated acetylenic acid, <span class="Chemical">nepheliosyne B (2), along with the previously described nepheliosyne A (1), have been isolated from the New Caledonian marine sponge Niphates sp. Their structures have been elucidated on the basis of extensive spectroscopic analyses. These metabolites exhibited a moderate cytotoxicity against K562, U266, SKM1, and Kasumi cancer cell lines.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23807547 PMCID: PMC3736423 DOI: 10.3390/md11072282
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structure of nepheliosynes A (1) and B (2).
1H NMR (500 MHz, CD3OD) and 13C NMR (125 MHz, CD3OD) data of nepheliosyne A (1).
| Position | δC (ppm)/Multiplicity | δH (ppm)/
| 1H-1H COSY/TOCSY | 1H-13C HMBC |
|---|---|---|---|---|
| 1 | 157.7, qC | |||
| 2 | 78.0, qC | |||
| 3 | 87.3, qC | |||
| 4 | 59.3, CH | 4.64, dd, 9.3, 3.5 | 5a, 6, 7 | 2, 3, 5, 6 |
| 5a | 45.6, CH2 | 1.74–1.71, m | 4, 5b, 6, 7 | 3, 4, 7 |
| 5b | 45.6, CH2 | 1.86–1.81, m | 4, 5a, 6, 7, 8 | 3, 4, 6, 7 |
| 6 | 68.4, CH | 3.84–3.79, m | 4, 5a, 5b, 7, 8 | 4, 5b |
| 7 | 38.7, CH2 | 1.45, m | 4, 6, 5a, 5b, 7, 8 | 8 |
| 8–18 | 30.8–30.4, CH2 | 1.30, m | 5a, 5b, 7, 17, 19 | |
| 19 | 24.1, CH2 | 1.59–1.55, m | 18, 20, 24, 25 | 20, 24, 25 |
| 20 | 38.6, CH2 | 2.61–2.49, m | 18, 19, 25, 26 | 18, 19, 21 |
| 21 | 215.4, qC | |||
| 22 | 78.0, CH | 4.05, dd, 8.1, 4.2 | 19, 23, 24 | 21, 23, 24 |
| 23a | 34.6, CH2 | 1.74–1.69, m | 22, 24, 25, 26 | 20 |
| 23b | 34.6, CH2 | 1.61–1.49, m | 22, 24, 25, 26 | 20 |
| 24 | 26.2, CH2 | 1.40–1.35, m | 20, 22, 23, 25, 26 | 19, 23, 25, 26, 27 |
| 25 | 28.0, CH2 | 2.14–2.05, m | 20, 23, 24, 26, 27 | 18, 19, 24, 26, 27 |
| 26 | 130.7, CH | 5.38, m | 20, 23, 24, 25, 28 | 25 |
| 27 | 130.9, CH | 5.38, m | 28, 29, 30, 31 | 28 |
| 28 | 27.8, CH2 | 2.14–2.05, m | 26, 27, 29, 30, 31 | 26, 27, 29, 30 |
| 29 | 26.7, CH2 | 1.56–1.49, m | 26, 27, 28, 30, 31 | 28, 30, 31 |
| 30 | 38.3, CH2 | 1.70–1.64, m | 26, 27, 28, 29, 31 | 28, 29, 31 |
| 31 | 62.6, CH | 4.33, dd, 6.7, 1.4 | 26, 27, 28, 29, 30, 34 | 30, 32, 33 |
| 32 | 83.1, qC | |||
| 33 | 82.9, qC | |||
| 34 | 52.3, CH | 5.17, t, 1.6 | 29, 30, 31, 37, 38 | 32, 33, 35, 36 |
| 35 | 85.6, qC | |||
| 36 | 85.9, qC | |||
| 37 | 62.6, CH | 4.36, dd, 6.6, 1.6 | 34, 38, 39, 40 | 35, 38 |
| 38 | 36.8, CH2 | 2.45, t, 6.1 | 31, 37, 39, 40 | 36, 37, 39, 40 |
| 39 | 129.2, CH | 5.64–5.54, m | 37, 38, 40, 41, 42 | 38, 42, 44 |
| 40 | 127.5, CH | 5.64–5.54, m | 37, 38, 39, 41, 42 | 41, 42, 44 |
| 41 | 36.3, CH2 | 2.38–2.25, m | 39, 40, 42 | 39, 40, 42, 43 |
| 42 | 72.2, CH | 4.15, dd, 6.3 | 39, 40, 41, 44 | 39, 40, 41, 43, 44 |
| 43 | 135.7, CH | 5.91, ddd, 15.4, 5.9, 1.3 | 41, 42, 44, 45 | 42, 44, 45 |
| 44 | 130.7, CH | 5.78, ddd, 15.4, 5.7, 1.2 | 41, 42, 43, 45 | 42, 43, 45, 46 |
| 45 | 62.5, CH | 4.83, d, 5.5 | 37, 42, 43, 44, 47 | 43, 44, 46, 47 |
| 46 | 84.4, qC | |||
| 47 | 74.4, CH | 2.90, d, 2.0 | 45 | 44, 45 |
1H NMR (500 MHz, CD3OD) and 13C NMR (125 MHz, CD3OD) data of nepheliosyne B (2).
| Position | δC (ppm)/Multiplicity | δH (ppm)/
| 1H-1H COSY/TOCSY | 1H-13C HMBC |
|---|---|---|---|---|
| 1 | 157.7, qC | |||
| 2 | 80.1, qC | |||
| 3 | 85.3, qC | |||
| 4 | 67.1, CH | 4.26, d, 5.02 | 5, 6, 7 | 1, 5 |
| 5 | 74.9, CH | 3.58, m | 4, 6, 7 | 4 |
| 6a | 33.5, CH2 | 1.69–1.64, m | 4, 5, 7, 8 | 4, 5 |
| 6b | 33.5, CH2 | 1.52–1.44, m | 4, 5, 7, 8 | 4, 5 |
| 7 | 30.8–30.4, CH2 | 1.29, m | 4, 5, 6, 8 | 8 |
| 8–18 | 30.8–30.4, CH2 | 1.29, m | 5a, 5b, 7, 17, 19 | |
| 19 | 24.1, CH2 | 1.59–1.55, m | 18, 20, 24, 25 | 20, 24, 25 |
| 20 | 38.6, CH2 | 2.61–2.49, m | 18, 19, 25, 26 | 18, 19, 21 |
| 21 | 215.0, qC | |||
| 22 | 78.0, CH | 4.05, dd, 8.1, 4.2 | 19, 23, 24 | 21, 23, 24 |
| 23a | 34.6, CH2 | 1.57–1.50, m | 22, 24, 25, 26 | 20 |
| 23b | 34.6, CH2 | 1.73–1.67, m | 22, 24, 25, 26 | 20 |
| 24 | 25.9, CH2 | 1.42–1.34, m | 20, 22, 23, 25, 26 | 19, 23, 25, 26, 27 |
| 25 | 28.0, CH2 | 2.14–2.05, m | 20, 23, 24, 26, 27 | 18, 19, 24, 26, 27 |
| 26 | 130.7, CH | 5.38, m | 20, 23, 24, 25, 28 | 25 |
| 27 | 130.9, CH | 5.38, m | 28, 29, 30, 31 | 28 |
| 28 | 27.8, CH2 | 2.14–2.05, m | 26, 27, 29, 30, 31 | 26, 27, 29, 30 |
| 29 | 26.2, CH2 | 1.58–1.49, m | 26, 27, 28, 30, 31 | 28, 30, 31 |
| 30 | 38.6, CH2 | 1.70–1.62, m | 26, 27, 28, 29, 31 | 28, 29, 31 |
| 31 | 62.6, CH | 4.33, dd, 6.7, 1.4 | 26, 27, 28, 29, 30, 34 | 30, 32, 33 |
| 32 | 83.1, qC | |||
| 33 | 82.9, qC | |||
| 34 | 52.4, CH | 5.17, t, 1.6 | 29, 30, 31, 37, 38 | 32, 33, 35, 36 |
| 35 | 85.6, qC | |||
| 36 | 85.9, qC | |||
| 37 | 62.6, CH | 4.36, dd, 6.6, 1.6 | 34, 38, 39, 40 | 35, 38 |
| 38 | 36.9, CH2 | 2.45, t, 6.1 | 31, 37, 39, 40 | 36, 37, 39, 40 |
| 39 | 127.6, CH | 5.64–5.54, m | 37, 38, 40, 41, 42 | 38, 42, 44 |
| 40 | 129.2, CH | 5.64–5.54, m | 37, 38, 39, 41, 42 | 41, 42, 44 |
| 41 | 36.4, CH2 | 2.38–2.25, m | 39, 40, 42 | 39, 40, 42, 43 |
| 42 | 72.2, CH | 4.15, dd, 6.3 | 39, 40, 41, 44 | 39, 40, 41, 43, 44 |
| 43 | 135.7, CH | 5.91, ddd, 15.4, 5.9, 1.3 | 41, 42, 44, 45 | 42, 44, 45 |
| 44 | 130.7, CH | 5.78, ddd, 15.4, 5.7, 1.2 | 41, 42, 43, 45 | 42, 43, 45, 46 |
| 45 | 62.6, CH | 4.83, d, 5.5 | 37, 42, 43, 44, 47 | 43, 44, 46, 47 |
| 46 | 84.4, qC | |||
| 47 | 75.1, CH | 2.90, d, 2.0 | 45 | 44, 45 |
Figure 2Partial structures (a, a′, b–e) of nepheliosynes A (1) and B (2).
IC50 values for compounds 1 and 2 for loss of cell metabolism (XTT assay) and cell number. Cells (10 × 104/mL) were incubated for 48 h at 37 °C with either increasing concentrations of compounds 1 and 2 in the 2.5–250 μM range. Cell metabolism was measured using the XTT kit assay as indicated in the Experimental section. IC50 values are representative of three experiments made in quadruplicates.
| Compounds | SKM1 (IC50) | U266 (IC50) | Kasumi (IC50) | K562 (IC50) |
|---|---|---|---|---|
| 1 | 250 | 170 | 200 | 200 |
| 2 | >250 | 200 | 150 | 150 |
Figure 3Niphates sp. (photo: Philippe Amade).